190 related articles for article (PubMed ID: 8537052)
1. Seromarkers of collagen I and III metabolism in active Crohn's disease. Relation to disease activity and response to therapy.
Kjeldsen J; Schaffalitzky de Muckadell OB; Junker P
Gut; 1995 Dec; 37(6):805-10. PubMed ID: 8537052
[TBL] [Abstract][Full Text] [Related]
2. Serum concentrations of type I and III procollagen propeptides in healthy children and girls with central precocious puberty during treatment with gonadotropin-releasing hormone analog and cyproterone acetate.
Hertel NT; Stoltenberg M; Juul A; Main KM; Müller J; Nielsen CT; Lorenzen I; Skakkebaek NE
J Clin Endocrinol Metab; 1993 Apr; 76(4):924-7. PubMed ID: 8473407
[TBL] [Abstract][Full Text] [Related]
3. Serum markers of collagen synthesis and degradation in skin diseases. Altered levels in diseases with systemic manifestation and during systemic glucocorticoid treatment.
Autio P; Risteli J; Kiistala U; Risteli L; Karvonen J; Oikarinen A
Arch Dermatol Res; 1993; 285(6):322-7. PubMed ID: 8215582
[TBL] [Abstract][Full Text] [Related]
4. Increased degradation of type I collagen in patients with inflammatory bowel disease.
Silvennoinen J; Risteli L; Karttunen T; Risteli J
Gut; 1996 Feb; 38(2):223-8. PubMed ID: 8801201
[TBL] [Abstract][Full Text] [Related]
5. Serum concentrations of type I collagen carboxyterminal telopeptide (ICTP) and type I procollagen carboxy-and aminoterminal propeptides (PICP, PINP) as markers of metastatic bone disease in breast cancer.
Tähtelä R; Thölix E
Anticancer Res; 1996; 16(4B):2289-93. PubMed ID: 8694558
[TBL] [Abstract][Full Text] [Related]
6. Connective tissue components in serum in multiple myeloma: analyses of propeptides of type I and type III procollagens, type I collagen telopeptide, and hyaluronan.
Abildgaard N; Nielsen JL; Heickendorff L
Am J Hematol; 1994 Jul; 46(3):173-8. PubMed ID: 8192146
[TBL] [Abstract][Full Text] [Related]
7. The use of serologic markers for collagen synthesis and degradation in systemic sclerosis.
Heickendorff L; Zachariae H; Bjerring P; Halkier-Sørensen L; Søndergaard K
J Am Acad Dermatol; 1995 Apr; 32(4):584-8. PubMed ID: 7896946
[TBL] [Abstract][Full Text] [Related]
8. Serum concentration of the cross-linked carboxyterminal telopeptide of type I collagen (ICTP) is a useful prognostic indicator in multiple myeloma.
Elomaa I; Virkkunen P; Risteli L; Risteli J
Br J Cancer; 1992 Aug; 66(2):337-41. PubMed ID: 1503907
[TBL] [Abstract][Full Text] [Related]
9. Serum propeptides of type I and III procollagens in renal transplant recipients. A comparison of cyclosporine and azathioprine treatment.
Heickendorff L; Frost L; Madsen JK; Pedersen EB
Nephron; 1994; 67(2):203-8. PubMed ID: 8072610
[TBL] [Abstract][Full Text] [Related]
10. Application of markers of collagen metabolism in serum and synovial fluid for assessment of disease process in patients with rheumatoid arthritis.
Hakala M; Aman S; Luukkainen R; Risteli L; Kauppi M; Nieminen P; Risteli J
Ann Rheum Dis; 1995 Nov; 54(11):886-90. PubMed ID: 7492237
[TBL] [Abstract][Full Text] [Related]
11. Hyaluronic acid and type III procollagen peptide in jejunal perfusion fluid as markers of connective tissue turnover.
Colombel JF; Hällgren R; Engström-Laurent A; Rambaud JC
Gastroenterology; 1989 Jan; 96(1):68-73. PubMed ID: 2909439
[TBL] [Abstract][Full Text] [Related]
12. Effects of systemic isotretinoin on serum markers of collagen synthesis and degradation.
Autio P; Risteli J; Palatsi R; Väänänen K; Vuori J; Risteli L; Oikarinen A
Acta Derm Venereol; 1993 Apr; 73(2):108-12. PubMed ID: 8103253
[TBL] [Abstract][Full Text] [Related]
13. [Serum concentration of pyridinoline cross-linked carboxy-terminal telopeptide of type-I collagen (ICTP) and carboxyterminal propeptide of human type I procollagen (PICP) in the diagnosis of bone metastases].
Koizumi M; Yamada Y; Takiguchi T; Suzuki C; Akashi T; Nomura E; Yamashita T; Ogata E
Kaku Igaku; 1996 Jan; 33(1):77-84. PubMed ID: 8819718
[TBL] [Abstract][Full Text] [Related]
14. Altered serum levels of type I collagen turnover indicators accompanied by IL-6 and IL-8 release in stable COPD.
Zeng YY; Hu WP; Zuo YH; Wang XR; Zhang J
Int J Chron Obstruct Pulmon Dis; 2019; 14():163-168. PubMed ID: 30655663
[TBL] [Abstract][Full Text] [Related]
15. Type I collagen degradation product (ICTP) gives information about the nature of bone metastases and has prognostic value in prostate cancer.
Kylmälä T; Tammela TL; Risteli L; Risteli J; Kontturi M; Elomaa I
Br J Cancer; 1995 May; 71(5):1061-4. PubMed ID: 7734300
[TBL] [Abstract][Full Text] [Related]
16. Systemic glucocorticoid treatment decreases serum concentrations of carboxyterminal propeptide of type I procollagen and aminoterminal propeptide of type III procollagen.
Oikarinen A; Autio P; Vuori J; Väänänen K; Risteli L; Kiistala U; Risteli J
Br J Dermatol; 1992 Feb; 126(2):172-8. PubMed ID: 1536783
[TBL] [Abstract][Full Text] [Related]
17. Markers of type I and type III collagen synthesis in serum as indicators of tissue growth during pregnancy.
Puistola U; Risteli L; Kauppila A; Knip M; Risteli J
J Clin Endocrinol Metab; 1993 Jul; 77(1):178-82. PubMed ID: 8325940
[TBL] [Abstract][Full Text] [Related]
18. Markers of type I collagen degradation and synthesis in the monitoring of treatment response in bone metastases from breast carcinoma.
Blomqvist C; Risteli L; Risteli J; Virkkunen P; Sarna S; Elomaa I
Br J Cancer; 1996 May; 73(9):1074-9. PubMed ID: 8624266
[TBL] [Abstract][Full Text] [Related]
19. Age related changes in biochemical markers of bone metabolism in horses.
Price JS; Jackson B; Eastell R; Goodship AE; Blumsohn A; Wright I; Stoneham S; Lanyon LE; Russell RG
Equine Vet J; 1995 May; 27(3):201-7. PubMed ID: 7556047
[TBL] [Abstract][Full Text] [Related]
20. Biochemical bone markers compared with bone density measurement by dual energy X-ray absorptiometry.
Lotz J; Steeger D; Hafner G; Ehrenthal W; Heine J; Prellwitz W
Calcif Tissue Int; 1995 Oct; 57(4):253-7. PubMed ID: 8673861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
